Literature DB >> 31437083

Neurocognitive profile of outpatients with unipolar depressive disorders.

Christine Schwert1, Maren Stohrer1, Steffen Aschenbrenner2, Matthias Weisbrod2,3, Annette Schröder1.   

Abstract

Introduction: It is widely accepted that major depressive disorder (MDD) is associated with impairments in several cognitive domains in inpatients, but cognitive functioning has barely been systematically investigated in depressed outpatients. The aims of the present study were to examine cognitive functioning in depressed outpatients in comparison with healthy controls and to determine whether cognitive deficits vary as a function of different disorder characteristics and demographic variables. Method: We compared 103 outpatients with recurrent MDD in an acute phase of the illness with 103 healthy controls matched on age, gender, and education level using a neuropsychological battery covering the domains of processing speed, attention, memory, working memory, and executive functions.
Results: Depressed outpatients were found to be impaired in all five assessed cognitive domains. These impairments varied as a function of the disorder characteristics, particularly severity of depression, intake of medication, age of depression onset, duration of current episode, and rumination as a psychological variable as well as age, premorbid intelligence, and education level as demographic variables. Conclusions: In the present study we tried to systematically investigate the impact of different disorder characteristics and demographic variables on the cognitive dysfunction of outpatients with MDD. The results indicate a moderate to severe cognitive impairment of outpatients with MDD and reveal an influence of different disease characteristics as well as demographics. These cognitive impairments may affect the course of the disease and should be considered in outpatient therapy.

Entities:  

Keywords:  Major depression; cognitive functioning; cognitive impairments; outpatients

Mesh:

Substances:

Year:  2019        PMID: 31437083     DOI: 10.1080/13803395.2019.1634180

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  5 in total

Review 1.  Neurocognitive deficits in depression: a systematic review of cognitive impairment in the acute and remitted state.

Authors:  Dominik Kriesche; Christian F J Woll; Nadja Tschentscher; Rolf R Engel; Susanne Karch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-01       Impact factor: 5.760

Review 2.  Shared and distinct brain fMRI response during performance of working memory tasks in adult patients with schizophrenia and major depressive disorder.

Authors:  Xiuli Wang; Bochao Cheng; Neil Roberts; Song Wang; Ya Luo; Fangfang Tian; Suping Yue
Journal:  Hum Brain Mapp       Date:  2021-08-25       Impact factor: 5.038

3.  Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients.

Authors:  Mark Stettner; Christoph Kleinschnitz; Michael Fleischer; Fabian Szepanowski; Muriel Tovar; Klaas Herchert; Hannah Dinse; Adam Schweda; Anne K Mausberg; Dagny Holle-Lee; Martin Köhrmann; Julia Stögbauer; Daniel Jokisch; Martha Jokisch; Cornelius Deuschl; Eva-Maria Skoda; Martin Teufel
Journal:  Neurol Ther       Date:  2022-08-26

4.  Weak associations between depressive symptom severity, depressive symptom clusters, and cognitive performance in young to middle-aged men without clinical depression.

Authors:  Sarah M Szymkowicz; Vonetta M Dotson; Rodney D Vanderploeg
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2020-10-29

5.  Mental Fatigue, But Not other Fatigue Characteristics, as a Candidate Feature of Obsessive Compulsive Personality Disorder in Patients with Anxiety and Mood Disorders-An Exploratory Study.

Authors:  Julija Gecaite-Stonciene; Naomi A Fineberg; Aurelija Podlipskyte; Julius Neverauskas; Alicja Juskiene; Narseta Mickuviene; Julius Burkauskas
Journal:  Int J Environ Res Public Health       Date:  2020-11-03       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.